Austin L. Gurney
Director/Miembro de la Junta en Immune-Onc Therapeutics, Inc. .
Perfil
Austin L.
Gurney is currently a Director at Immune-Onc Therapeutics, Inc. He was previously a Senior Scientist at Genentech, Inc. and a Vice President-Molecular & Cellular Biology at OncoMed Pharmaceuticals, Inc. from 2004 to 2011.
He has an undergraduate degree from Rensselaer Polytechnic Institute and a doctorate from Case Western Reserve University School of Medicine.
Cargos activos de Austin L. Gurney
| Empresas | Cargo | Inicio |
|---|---|---|
Immune-Onc Therapeutics, Inc.
 Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Director/Miembro de la Junta | 08/11/2022 |
Antiguos cargos conocidos de Austin L. Gurney.
| Empresas | Cargo | Fin |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Director Técnico/Científico/I+D | 21/12/2018 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Director Técnico/Científico/I+D | - |
Formación de Austin L. Gurney.
| Rensselaer Polytechnic Institute | Undergraduate Degree |
| Case Western Reserve University School of Medicine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Austin L. Gurney
